Study of Therapeutic Options for Subjects Discontinuing Efalizumab and Experiencing Disease Recurrence
Status:
Completed
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
This is a pilot investigational study of the appropriate therapeutic regimens to treat
subjects experiencing inflammatory recurrence (rebound) of psoriatic disease upon
discontinuation of efalizumab therapy and of the biological mechanisms involved in
inflammatory disease recurrence and control.